NCT05237297

Study to Evaluate Pharmacokinetic Drug Interactions and Safety of Naproxen, Aceclofenac, Celecoxib and Ilaprazole

A Randomized, Open-label, Multiple-dose, Crossover Clinical Trial to Investigate the Pharmacokinetic Drug Interactions and Safety After Co-administration of Ilaprazole and NSAID in Healthy Adults

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 72 (actual)
• Sponsor: Il-Yang Pharm. Co., Ltd. · Industry
• Sex: All
• Age: 19 Years – 55 Years
• Healthy volunteers: Accepted

Summary

This study evaluate the pharmacokinetic drug interactions and safety after co-administration of ilaprazole and NSAID in healthy adults.

Conditions

• Drug Interaction Potentiation

Interventions

Type	Name	Description
DRUG	Ilaprazole	Ilaprazole 10mg
DRUG	Naproxen	Naproxen 500mg
DRUG	Aceclofenac	Aceclofenac 100mg
DRUG	Celecoxib	Celecoxib 200mg

Timeline

• Start date: 2022-02-17
• Primary completion: 2022-07-13
• Completion: 2022-07-27
• First posted: 2022-02-14
• Last updated: 2023-06-28

Locations

1 site across 1 country: South Korea